ENTEROBIOTIX
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome modulating drugs composed of bacterial communities derived directly from the human gastrointestinal tract associated with imbalances of bacteria in the human gut, enabling physicians to prevent and treat debilitating infections and diseases.
ENTEROBIOTIX
Industry:
Biotechnology Clinical Trials Health Care Life Science
Founded:
2017-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.enterobiotix.com
Total Employee:
1+
Status:
Active
Total Funding:
18 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema Office 365 Mail
Current Advisors List
Current Employees Featured
Founder
Investors List
Kineticos Ventures
Kineticos Ventures investment in Series A - EnteroBiotix
Scottish Enterprise
Scottish Enterprise investment in Series A - EnteroBiotix
Thairm Bio
Thairm Bio investment in Series A - EnteroBiotix
SIS Ventures
SIS Ventures investment in Series A - EnteroBiotix
Bank Workers Charity
Bank Workers Charity investment in Seed Round - EnteroBiotix
University of Aberdeen
University of Aberdeen investment in Seed Round - EnteroBiotix
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - EnteroBiotix
Equity Gap
Equity Gap investment in Seed Round - EnteroBiotix
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - EnteroBiotix
Equity Gap
Equity Gap investment in Seed Round - EnteroBiotix
Official Site Inspections
http://www.enterobiotix.com Semrush global rank: 1.54 M Semrush visits lastest month: 16.97 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "EnteroBiotix"
EnteroBiotix - Crunchbase Company Profile & Funding
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. The company's offerings include developing and advancing novel microbiome-modulating drugs composed of bacterial …See details»
EnteroBiotix Company Profile 2024: Valuation, Funding …
EnteroBiotix General Information Description. Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. The company focuses on creating microbial therapeutics for patients with serious …See details»
Life at EnteroBiotix — EnteroBiotix
If you think you would be a good fit for our team then please email your CV and covering letter to [email protected]. Find out more about our donor programme. Visit Number2.org . …See details»
EnteroBiotix - LinkedIn
EnteroBiotix | 5,897 followers on LinkedIn. Mastering the microbiome, transforming lives® | EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the ...See details»
EnteroBiotix CEO and Key Executive Team | Craft.co
EnteroBiotix's Chief Executive Officer is Michael J. Butler. Other executives include Gregor Russell, COO; James R. McIlroy, Chief Technical Officer. See the full leadership team at Craft.See details»
A leading gut therapeutics company — EnteroBiotix
Founded EnteroBiotix with the vision of building the world’s premier microbiome therapeutics company. Formed company, raised £47m, established technology platforms, initiated and …See details»
EnteroBiotix - Contacts, Employees, Board Members, Advisors
Organization. EnteroBiotix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... EnteroBiotix has 1 board member or …See details»
Enterobiotix - Company Profile - Tracxn
Nov 18, 2024 Enterobiotix ranks 21st among 154 active competitors. 61 of its competitors are funded while 30 have exited. Overall, Enterobiotix and its competitors have raised over $3.62B …See details»
EnteroBiotix - Funding, Financials, Valuation & Investors
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
EnteroBiotix Completes £27m Financing Round to Advance Clinical …
Apr 4, 2024 GLASGOW, United Kingdom, April 04, 2024 (GLOBE NEWSWIRE) -- EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full …See details»
EnteroBiotix secures $21.5M series A to advance microbiome drug ...
Sep 8, 2021 EnteroBiotix has rounded up $21.5 million in a series A financing to advance a pipeline of drugs targeting the microbiome, which is believed to play a role in overall health. | …See details»
EnteroBiotix | CipherBio
Explore EnteroBiotix's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
EnteroBiotix Announces MHRA License Approval and …
Sep 10, 2018 EnteroBiotix, a leading clinical stage microbiome therapeutics company, has been granted a manufacturers ‘specials’ license from the Medicines and Healthcare Products …See details»
James Clark appointed chief technology officer at PredictImmune
Nov 25, 2019 PredictImmune has welcomed James Clark to its ranks as the company’s new chief technology officer. Previously chief executive officer of EnteroBiotix, specialists in the …See details»
EnteroBiotix Raises over $21m in Series A Financing to Advance its ...
Glasgow, Scotland – 7th September 2021 – EnteroBiotix, a biopharmaceutical company developing novel high-diversity microbial therapeutics that enhance the gut microbiome and …See details»
EnteroBiotix Raises over $21m in Series A Financing to Advance its ...
GLASGOW, Scotland, Sept. 7, 2021 /PRNewswire/ -- EnteroBiotix, a biopharmaceutical company developing novel high-diversity microbial therapeutics that enhance the gut microbiome and …See details»
EnteroBiotix lands $34m to take microbiome therapeutics into …
Apr 5, 2024 Microbiome therapeutics company EnteroBiotix has successfully concluded a $34m funding round to support the advancement of clinical programs targeting multiple chronic …See details»
News — EnteroBiotix
EnteroBiotix completed enrolment ahead of its planned schedule, dosing 62 participants with constipation predominant IBS and 60 participants with diarrhoea predominant IBS Read More …See details»
Newsroom - EnteroBiotix
EnteroBiotix newsroom. Filter news by category. EnteroBiotix in the news Events News Past events Press Release News & press releases. News. 18 Nov 2024. EnteroBiotix Completes …See details»